Skip to main navigation Skip to main content
  • KSPTM
  • E-Submission

PHD : Parasites, Hosts and Diseases

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

4
results for

"Chagas disease"

Article category

Keywords

Publication year

Authors

Funded articles

"Chagas disease"

Original Article

In vitro anti-Trypanosoma cruzi activity of methanolic extract of Bidens pilosa and identification of active compounds by gas chromatography-mass spectrometry analysis
Gabriel Enrique Cázares-Jaramillo, Zinnia Judith Molina-Garza, Itza Eloisa Luna-Cruz, Luisa Yolanda Solís-Soto, José Luis Rosales-Encina, Lucio Galaviz-Silva
Parasites Hosts Dis 2023;61(4):405-417.
Published online November 28, 2023
DOI: https://doi.org/10.3347/PHD.23069
Chagas disease, caused by Trypanosoma cruzi parasite, is a significant but neglected tropical public health issue in Latin America due to the diversity of its genotypes and pathogenic profiles. This complexity is compounded by the adverse effects of current treatments, underscoring the need for new therapeutic options that employ medicinal plant extracts without negative side effects. Our research aimed to evaluate the trypanocidal activity of Bidens pilosa fractions against epimastigote and trypomastigote stages of T. cruzi, specifically targeting the Brener and Nuevo León strains—the latter isolated from Triatoma gerstaeckeri in General Terán, Nuevo León, México. We processed the plant’s aerial parts (stems, leaves, and flowers) to obtain a methanolic extract (Bp-mOH) and fractions with varying solvent polarities. These preparations inhibited more than 90% of growth at concentrations as low as 800 μg/ml for both parasite stages. The median lethal concentration (LC50) values for the Bp-mOH extract and its fractions were below 500 μg/ml. Tests for cytotoxicity using Artemia salina and Vero cells and hemolytic activity assays for the extract and its fractions yielded negative results. The methanol fraction (BPFC3MOH1) exhibited superior inhibitory activity. Its functional groups, identified as phenols, enols, alkaloids, carbohydrates, and proteins, include compounds such as 2-hydroxy-3-methylbenzaldehyde (50.9%), pentadecyl prop-2-enoate (22.1%), and linalool (15.4%). Eight compounds were identified, with a match confirmed by the National Institute of Standards and Technology (NIST-MS) software through mass spectrometry analysis.

Citations

Citations to this article as recorded by  Crossref logo
  • Inhibitory Activity of Compounds Obtained from Streptomyces Against Trypanosoma cruzi
    Jorge Andrés Delgado-Garduño, Lucio Galaviz-Silva, Ma Guadalupe Rojas-Verde, Joel Horacio Elizondo-Luevano, Lidia Baylón-Pacheco, José Luis Rosales-Encina, Guadalupe Gutiérrez-Soto, Zinnia Judith Molina-Garza
    Pathogens.2025; 14(7): 638.     CrossRef
  • Nanostructured Polyurethane‐Collagen Hydrogels: Bioactive Crosslinked Networks for Enhanced Wound Healing
    María I. León‐Campos, Jesús A. Claudio‐Rizo, Luis E. Cobos‐Puc, Denis A. Cabrera‐Munguía, Anilú Rubio‐Rios, Ernesto Oyervides‐Muñoz, Angélica Velázquez‐Arrellano
    Journal of Biomedical Materials Research Part A.2025;[Epub]     CrossRef
  • Assessment of Anticancer Properties of Argemone mexicana L. and Berberine: A Comparative Study
    Joel H. Elizondo-Luevano, Ramiro Quintanilla-Licea, Imelda N. Monroy-García, Miroslava Kačániová, Uziel Castillo-Velázquez, Aldo F. Bazaldúa-Rodríguez, Lourdes M. Garza-Vega, Ángel D. Torres-Hernández, Abelardo Chávez-Montes
    Plants.2024; 13(10): 1374.     CrossRef
  • In Vitro Evaluation of Anti-Hemolytic and Cytotoxic Effects of Traditional Mexican Medicinal Plant Extracts on Human Erythrocytes and Cell Cultures
    Joel H. Elizondo-Luevano, Ramiro Quintanilla-Licea, Sandra L. Castillo-Hernández, Eduardo Sánchez-García, Minerva Bautista-Villarreal, Georgia M. González-Meza, Marcela A. Gloria-Garza, Osvelia E. Rodríguez-Luis, Maciej Ireneusz Kluz, Miroslava Kačániová
    Life.2024; 14(9): 1176.     CrossRef
  • 3,520 View
  • 138 Download
  • 5 Web of Science
  • Crossref

Brief Communications

Detection of Human Anti-Trypanosoma cruzi Antibody with Recombinant Fragmented Ribosomal P Protein
Yeong Hoon Kim, Zhaoshou Yang, Jihoo Lee, Hye-Jin Ahn, Chom-Kyu Chong, Wagner Maricondi, Ronaldo F. Dias, Ho-Woo Nam
Korean J Parasitol 2019;57(4):435-437.
Published online August 31, 2019
DOI: https://doi.org/10.3347/kjp.2019.57.4.435
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, and is endemic in many Latin American countries. Diagnosis is based on serologic testing and the WHO recommends two or more serological tests for confirmation. Acidic ribosomal P protein of T. cruzi showed strong reactivity against positive sera of patients, and we cloned the protein after fragmenting it to enhance its antigenicity and solubility. Twelve positive sera of Chagas disease patients were reacted with the fragmented ribosomal P protein using western blot. Detection rate and density for each fragment were determined. Fragments F1R1, F1R2, and F2R1 showed 100% rate of detection, and average density scoring of 2.00, 1.67, and 2.42 from a maximum of 3.0, respectively. Therefore, the F2R1 fragment of the ribosomal P protein of T. cruzi could be a promising antigen to use in the diagnosis of Chagas disease in endemic regions with high specificity and sensitivity.

Citations

Citations to this article as recorded by  Crossref logo
  • In vitro diagnostic methods of Chagas disease in the clinical laboratory: a scoping review
    Luis C. Ascanio, Savannah Carroll, Alberto Paniz-Mondolfi, Juan David Ramírez
    Frontiers in Microbiology.2024;[Epub]     CrossRef
  • A refined genome phage display methodology delineates the human antibody response in patients with Chagas disease
    André Azevedo Reis Teixeira, Luis Rodriguez Carnero, Andréia Kuramoto, Fenny Hui Fen Tang, Carlos Hernique Gomes, Natalia Bueno Pereira, Léa Campos de Oliveira, Regina Garrini, Jhonatas Sirino Monteiro, João Carlos Setubal, Ester Cerdeira Sabino, Renata P
    iScience.2021; 24(6): 102540.     CrossRef
  • 5,941 View
  • 99 Download
  • 2 Web of Science
  • Crossref
Quantification of Immunoglobulin G against Trypanosoma cruzi in Individuals with Chronic Chagas Disease Treated with Nifurtimox and Evaluated in Prolonged Follow-Up
Gabriela Mun?oz, Camilo Vergara, Gabriela Marti?nez, Werner Apt, Ine?s Zulantay
Korean J Parasitol 2019;57(1):39-41.
Published online February 26, 2019
DOI: https://doi.org/10.3347/kjp.2019.57.1.39
In the indeterminate chronic period of Chagas disease (ChD) the treatment has not been conclusive, because the serological negativization requires many years. This study aims to evaluate the efficacy of nifurtimox (NF) in the treatment of chronic ChD in prolonged follow-up by serological techniques of indirect immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA) IgG comparing 2 groups of patients, treated and non treated. Mann-Whitney test was performed for ELISA and IFA, with significant difference between the groups (P < 0.05). IgG levels were lower in individuals treated compared with untreated patients, indicating chemotherapeutic efficacy in prolonged follow-up.

Citations

Citations to this article as recorded by  Crossref logo
  • Changes in lipid abundance are associated with disease progression and treatment response in chronic Trypanosoma cruzi infection
    Juan Carlos Gabaldón-Figueira, Albert Ros-Lucas, Nieves Martínez-Peinado, Gavin Blackburn, Irene Losada-Galvan, Elizabeth Posada, Cristina Ballart, Elisa Escabia, Jordi Capellades, Oscar Yanes, María-Jesús Pinazo, Joaquim Gascón, Julio Alonso-Padilla
    Parasites & Vectors.2024;[Epub]     CrossRef
  • Discrete Typing Units of Trypanosoma cruzi Identified by Real-Time PCR in Peripheral Blood and Dejections of Triatoma infestans Used in Xenodiagnosis Descriptive Study
    Inés Zulantay, Gabriela Muñoz, Daniela Liempi, Tamara Rozas, María José Manneschi, Catalina Muñoz-San Martín, Carezza Botto-Mahan, Werner Apt, Gonzalo Cabrera
    Pathogens.2022; 11(7): 787.     CrossRef
  • Differential phenotypic and functional profile of epitope-specific cytotoxic CD8+ T cells in benznidazole-treated chronic asymptomatic Chagas disease patients
    Adriana Egui, Manuel Carlos López, Inmaculada Gómez, Marina Simón, Manuel Segovia, M. Carmen Thomas
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(3): 165629.     CrossRef
  • Detection of Trypanosoma cruzi by PCR in adults with chronic Chagas disease treated with nifurtimox
    Camilo Vergara, Gabriela Muñoz, Gabriela Martínez, Werner Apt, Inés Zulantay, Jude Marek Przyborski
    PLOS ONE.2019; 14(8): e0221100.     CrossRef
  • Chronic Chagas disease: Quantification of Trypanosoma cruzi in peripheral blood and dejections of Triatoma infestans fed by xenodiagnosis in patients with and without cardiopathy
    Werner Apt, Daniela Carrasco, Cristian Fuentealba, Mauricio Canals, Gabriela Muñoz, Miguel Saavedra, Juan-Paul Castillo, Inés Zulantay
    Acta Tropica.2019; 200: 105167.     CrossRef
  • 6,268 View
  • 90 Download
  • 5 Web of Science
  • Crossref
Mini Review

Prehistoric Pathoecology as Represented by Parasites of a Mummy from the Perua?u Valley, Brazil
Karl J Reinhard, Adauto Ara?jo
Korean J Parasitol 2016;54(5):585-590.
Published online October 31, 2016
DOI: https://doi.org/10.3347/kjp.2016.54.5.585
Paleopathologists have begun exploring the pathoecology of parasitic diseases in relation to diet and environment. We are summarizing the parasitological findings from a mummy in the site of Lapa do Boquete, a Brazilian cave in the state of Minas Gerais. These findings in context of the archaeology of the site provided insights into the pathoecology of disease transmission in cave and rockshelter environments. We are presenting a description of the site followed by the evidence of hookworm, intestinal fluke, and Trypanosoma infection with resulting Chagas disease in the mummy discovered in the cave. These findings are used to reconstruct the transmission ecology of the site.

Citations

Citations to this article as recorded by  Crossref logo
  • Using sacrum stored in museums and anthropological depositories for archaeoparasitological research
    Maria Olegovna Filimonova, Sergey Mikhailovich Slepchenko
    Journal of Archaeological Science: Reports.2021; 39: 103173.     CrossRef
  • Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Trypanosoma cruzi-Triggered Disease
    Luíza Dantas-Pereira, Rubem Menna-Barreto, Joseli Lannes-Vieira
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Ancient Echinostome Eggs Discovered in Archaeological Strata Specimens from a Baekje Capital Ruins of South Korea
    Min Seo, Sang-Yuck Shim, Hwa Young Lee, Yongjun Kim, Jong Ha Hong, Ji Eun Kim, Jong-Yil Chai, Dong Hoon Shin
    Journal of Parasitology.2020; 106(1): 184.     CrossRef
  • Paleoparasitology and pathoecology in Russia: Investigations and perspectives
    Sergey Slepchenko, Karl Reinhard
    International Journal of Paleopathology.2018; 22: 39.     CrossRef
  • Reestablishing rigor in archaeological parasitology
    Karl Reinhard
    International Journal of Paleopathology.2017; 19: 124.     CrossRef
  • A Case of Ectopic Paragonimiasis in a 17th Century Korean Mummy
    D. H. Shin, Y.-S. Kim, D. S. Yoo, M. J. Kim, C. S. Oh, J. H. Hong, E. Lee, J. Y. Chai, M. Seo
    Journal of Parasitology.2017; 103(4): 399.     CrossRef
  • 9,470 View
  • 175 Download
  • 7 Web of Science
  • Crossref